白细胞介素-6在预测有症状孕妇早产方面优于胎盘α微球蛋白-1
本研究为前瞻性观察性研究,纳入136例24+0至34+6周妊娠、胎膜完整的先兆早产单胎孕妇,比较阴道胎盘α微球蛋白-1与白细胞介素-6联合宫颈长度等指标预测早产。结果显示白细胞介素-6单变量模型F2评分多数优于胎盘α微球蛋白-1,多变量模型在平衡数据集下预测7天内分娩F2评分达0.88±0.2。
要点
- 白细胞介素-6单变量模型预测7天内分娩F2评分0.38,高于胎盘α微球蛋白-1的0.30。
- 多变量模型在非平衡数据集预测37周内分娩F2评分0.73,优于多数单变量模型。
- 平衡数据集下多变量模型预测7天内分娩F2评分0.88±0.2,阳性预测值0.86±0.02。
核心结论
- 包含白细胞介素-6的多变量评估可能有助于更精准的治疗,从而减少不必要的住院和避免不必要的母胎治疗。
研究设计与样本
- 前瞻性观察性研究,纳入136例24+0至34+6周妊娠、胎膜完整的先兆早产单胎孕妇。
- 阴道液用拭子采集,PartoSure试验检测胎盘α微球蛋白-1,电化学发光免疫分析法检测白细胞介素-6,经阴道超声测量宫颈长度。
- 从临床记录中获取产科变量和新生儿详情,拟合单变量和多变量二元逻辑回归模型预测分娩时间。
主要发现
- 136例中8例失访、7例排除,剩余121例中22例7天内分娩、31例14天内分娩、30例≤34周分娩、55例≤37周分娩。
- 单变量模型中白细胞介素-6对数转换的F2评分多数最高:7天内分娩0.38 vs 胎盘α微球蛋白-1 0.30;14天内分娩0.58 vs 0.29;≤34周分娩0.56 vs 0.29;≤37周分娩0.61 vs 0.16。
- 非平衡数据集多变量模型F2评分:7天内分娩0.63、14天内分娩0.54、≤34周分娩0.62、≤37周分娩0.73。
- 平衡数据集多变量模型预测7天内分娩F2评分0.88±0.2,阳性预测值0.86±0.02,阴性预测值0.89±0.03。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Threatened preterm labor is the major cause of hospital admission during the second half of pregnancy. An early diagnosis is crucial for adopting pharmacologic measures to reduce perinatal mortality and morbidity. Current diagnostic criteria are based on symptoms and short cervical length. However, there is a high false-positive rate when using these criteria, which implies overtreatment, causing unnecessary side effects and an avoidable economic burden. OBJECTIVE: This study aimed to compare the use of placental alpha microglobulin-1 and interleukin-6 as vaginal biomarkers combined with cervical length and other maternal characteristics to improve the prediction of preterm delivery in symptomatic women. STUDY DESIGN: A prospective observational study was conducted in women with singleton pregnancies complicated by threatened preterm labor with intact membranes at 24+0 to 34+6 weeks of gestation. A total of 136 women were included in this study. Vaginal fluid was collected with a swab for placental alpha microglobulin-1 determination using the PartoSure test, interleukin-6 was assessed by electrochemiluminescence immunoassay, cervical length was measured by transvaginal ultrasound, and obstetrical variables and newborn details were retrieved from clinical records. These characteristics were used to fit univariate binary logistic regression models to predict time to delivery <7 days, time to delivery <14 days, gestational age at delivery ≤34 weeks, and gestational age at delivery ≤37 weeks, and multivariate binary logistic regression models were fitted with imbalanced and balanced data. Performance of models was assessed by their F2-scores and other metrics, and the association of their variables with a risk or a protective factor was studied. RESULTS: A total of 136 women were recruited, of whom 8 were lost to follow-up and 7 were excluded. Of the remaining 121 patients, 22 had a time to delivery <7 days and 31 had a time to delivery <14 days, and 30 deliveries occurred with a gestational age at delivery ≤34 weeks and 55 with a gestational age at delivery ≤37 weeks. Univariate binary logistic regression models fitted with the log transformation of interleukin-6 showed the greatest F2-scores in most studies, which outperformed those of models fitted with placental alpha microglobulin-1 (log[interleukin-6] vs placental alpha microglobulin-1 in time to delivery <7 days: 0.38 vs 0.30; time to delivery <14 days: 0.58 vs 0.29; gestational age at delivery ≤34 weeks: 0.56 vs 0.29; gestational age at delivery ≤37 weeks: 0.61 vs 0.16). Multivariate logistic regression models fitted with imbalanced data sets outperformed most univariate models (F2-score in time to delivery <7 days: 0.63; time to delivery <14 days: 0.54; gestational age at delivery ≤34 weeks: 0.62; gestational age at delivery ≤37 weeks: 0.73). The performance of prediction of multivariate models was drastically improved when data sets were balanced, and was maximum for time to delivery <7 days (F2-score: 0.88±0.2; positive predictive value: 0.86±0.02; negative predictive value: 0.89±0.03). CONCLUSION: A multivariate assessment including interleukin-6 may lead to more targeted treatment, thus reducing unnecessary hospitalization and avoiding unnecessary maternal-fetal treatment.
引用
- Roca-Prats A, Diaz-Martinez A, Albaladejo-Belmonte M, et al. Outperformance of interleukin-6 over placental alpha microglobulin-1 in predicting preterm delivery in symptomatic women. Am J Obstet Gynecol MFM. 2023. PMID: 37549734. doi:10.1016/j.ajogmf.2023.101125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。